- Home
- RPRX vs CNC Comparison
RPRX vs CNC Comparison
Compare RPRX & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | CNC |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 20.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | CNC |
|---|---|---|
| Price | $45.16 | $43.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 17 |
| Target Price | ★ $47.75 | $41.25 |
| AVG Volume (30 Days) | 4.2M | ★ 6.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $39.10 | $8.24 |
| Revenue Next Year | $5.02 | $1.34 |
| P/E Ratio | $25.25 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.66 | $25.08 |
| 52 Week High | $46.14 | $66.03 |
Technical Indicators
Market Signals| Indicator | RPRX | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 73.30 | 54.73 |
| Support Level | $42.50 | $38.85 |
| Resistance Level | $46.14 | $40.83 |
| Average True Range (ATR) | 1.00 | 1.63 |
| MACD | 0.19 | -0.00 |
| Stochastic Oscillator | 82.91 | 86.51 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.